Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia

• Status: Active, not recruiting
• Trial end date: 2022-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to find out whether adding insulin after current colorectal cancer surgery promotes making and keeping proteins in the body, and to find out whether or not this effect can be further increased by increasing the amount of protein given.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: McGill University Health Center; McGill University Health Centre/Research Institute of the McGill University Health Centre
• Collaborator: Canadian Institutes of Health Research (CIHR)
• Treatments: Amino-acid, glucose, and electrolyte solution; Anabolic Agents; Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists class<3

• age>18 years

• colorectal surgery for non-metastatic colorectal adenocarcinoma including right and left hemicolectomy, transverse, subtotal and total colectomy sigmoid and low anterior resection

• ability to give informed consent

Exclusion Criteria:

• BMI>30 Kg/meter squared

• confirmed diagnosis of diabetes mellitus or a HbA1c>6.0%

• significant cardiorespiratory, hepatic, renal and neurological disease

• musculoskeletal or neuromuscular disease

• ingestion of drugs known to affect protein, glucose and lipid metabolism (e.g. steroids)

• severe anemia (hemoglobin<10 g/dL

• pregnancy

• history of severe sciatica, back surgery or other conditions which contraindicate the use of epidural catheters